Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Dova Pharmaceuticals, Inc. (NASDAQ: DOVA).

Full DD Report for DOVA

You must become a subscriber to view this report.


Recent News from (NASDAQ: DOVA)

Dova Pharmaceuticals' (DOVA) CEO Alex Sapir on Q1 2018 Results - Earnings Call Transcript
Dova Pharmaceuticals, Inc. (DOVA) Q1 2018 Earnings Conference Call May 9, 2018 04:30 PM ET Executives Alex Sapir - President and CEO Mark Hahn - CFO Lee Allen - Chief Medical Officer Kevin Laliberte - SVP, Product Development Analysts Eric Joseph - JPMorgan Eun Yang - J...
Source: SeekingAlpha
Date: May, 12 2018 04:22
Dova Pharmaceuticals misses by $0.05
Dova Pharmaceuticals (NASDAQ: DOVA ): Q1 EPS of -$0.52 misses by $0.05 . More news on: Dova Pharmaceuticals, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 09 2018 16:31
Dova Pharmaceuticals Reports First Quarter 2018 Operating and Financial Results
PDUFA date for avatrombopag of May 21, 2018 Conference call scheduled for 4:30 p.m. ET today DURHAM, N.C., May 09, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for ra...
Source: GlobeNewswire
Date: May, 09 2018 16:05
Dova Pharmaceuticals to Announce First Quarter 2018 Financial Results on May 9, 2018
DURHAM, N.C., May 02, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) will host a conference call on Wednesday, May 9, 2018 at 4:30 p.m. ET to discuss first quarter 2018 financial results and recent operational highlights. A question-and-answer session will follow Dova's r...
Source: GlobeNewswire
Date: May, 02 2018 16:30
Investor Expectations to Drive Momentum within Horizon Bancorp (IN), Allegiant Travel, Littelfuse, Dova Pharmaceuticals, BOK Financial, and Northfield - Discovering Underlying Factors of Influence
NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Horizon Bancorp (IN) (NASDAQ:HBNC), Allegiant Travel Company (NASDAQ:ALG...
Source: GlobeNewswire
Date: April, 03 2018 07:55
Week In Review: James Watson To Lead New Shenzhen Biopharma Research Center
Industry Developments James Watson, who co-discovered the double-helix structure of DNA in 1953, will lead a new international life science research center in the International Bio Valley, located in Shenzhen's Dapeng New Area. A groundbreaking ceremony was held last Friday with Dr. Watson i...
Source: SeekingAlpha
Date: March, 25 2018 09:31
Blog Exposure - Dova Pharma Inked Agreement with Fosun Pharma for Distribution of Avatrombopag in Mainland China and Hong Kong
Stock Monitor: BioDelivery Sciences Intl. Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 21, 2018 / Active-Investors.com has just released a free research report on Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) ("Dova"). If you want access to this report all you need to do is si...
Source: ACCESSWIRE IA
Date: March, 21 2018 07:20
Dova Pharmaceuticals Signs Exclusive Distribution Agreement with Fosun Pharma For Mainland China and Hong Kong
DURHAM, N.C., March 19, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for rare diseases where there is a high unmet need, entered into an agreement through its wholly owned su...
Source: GlobeNewswire
Date: March, 19 2018 08:00
Dova Pharmaceuticals (DOVA) Presents At 38th Annual Cowen And Company Healthcare Conference - Slideshow
The following slide deck was published by Dova Pharmaceuticals in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 15 2018 14:19
Dova Pharmaceuticals to Present at Cowen 38th Annual Health Care Conference
DURHAM, N.C., March 08, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Cowen 38 th Annual Health Care Conference on Wednesday, March 14, 2018 at 10:40 a.m. ET i...
Source: GlobeNewswire
Date: March, 08 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1827.1326.6527.3226.56182,081
2018-05-1727.1326.6527.3226.56182,081

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-18103,636137,34175.4589Short
2018-05-1753,58971,22475.2401Short
2018-05-1648,97567,68772.3551Short
2018-05-1538,77552,41673.9755Short
2018-05-1490,441131,27568.8943Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on DOVA.


About Dova Pharmaceuticals, Inc. (NASDAQ: DOVA)

Logo for Dova Pharmaceuticals, Inc. (NASDAQ: DOVA)

Not available

 

Contact Information

     

     

    Current Share Structure

       


      Recent Filings from (NASDAQ: DOVA)

      Quarterly report with a continuing view of a company's financial position
      Filing Type: 10-QFiling Source: edgar
      Filing Date: May, 09 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: May, 09 2018
      Official notification to shareholders of matters to be brought to a vote (Proxy)
      Filing Type: DEF 14AFiling Source: edgar
      Filing Date: April, 27 2018
      Additional proxy soliciting materials - definitive
      Filing Type: DEFA14AFiling Source: edgar
      Filing Date: April, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 20 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: April, 03 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 27 2018
      Report of unscheduled material events or corporate changes.
      Filing Type: 8-KFiling Source: edgar
      Filing Date: March, 15 2018
      Prospectus filed under Rule 424(b)(4)
      Filing Type: 424B4Filing Source: edgar
      Filing Date: February, 23 2018
      General form for registration of securities under the Securities Act of 1933
      Filing Type: S-1Filing Source: edgar
      Filing Date: February, 20 2018

       

       


      Daily Technical Chart for (NASDAQ: DOVA)

      Daily Technical Chart for (NASDAQ: DOVA)


      Stay tuned for daily updates and more on (NASDAQ: DOVA)

      It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

      More to come on (NASDAQ: DOVA)

      Do your DD and if you choose, be ready to go!


       

      The Research: All source information contained in this email is from the public sources mentioned below.

       

       
       

      Thank you

      The Subway Trader
      @TheSubwayTrader

       

       


      Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DOVA is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of DOVA and does not buy, sell, or trade any shares of DOVA. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/